Last year, four PhD students from the MeilerLab at Leipzig University’s Institute for Drug Discovery launched the lab’s first spin-off: AI-Driven Therapeutics. Just a few days ago, they received the prestigious Startup Award from the German Federal Ministry for Economic Affairs and Climate Action (Bundesministerium für Wirtschaft und Klimaschutz) as part of the national competition “Gründungswettbewerb – Digitale Innovationen”.
Their award-winning innovation: an AI-powered platform that dramatically accelerates protein design. What once took weeks of manual work can now be accomplished in hours – unlocking new potential in early-stage drug discovery and biotechnology research. The founding team from our lab combines deep expertise in structural biology, machine learning, and computational chemistry to build tools that empower scientists worldwide.
With this national recognition, AI-Driven Therapeutics joins the growing wave of deep tech startups emerging from universities.
